title: A case report of neurosarcoidosis successfully treated with an infliximab biosimilar after a relapse while on dual therapy.
authors.affiliation: Southend University Hospital, Essex, UK. dmerinopoulos@yahoo.com.
authors.forename: Dimos
authors.initials: D
authors.lastname: Merinopoulos
authors.affiliation: Southend University Hospital, Essex, UK.
authors.forename: Fiona
authors.initials: F
authors.lastname: Hayes
authors.affiliation: Southend University Hospital, Essex, UK.
authors.forename: David A
authors.initials: DA
authors.lastname: Gallagher
authors.affiliation: Southend University Hospital, Essex; and Anglia Ruskin University, Cambridge, UK.
authors.forename: Bhaskar
authors.initials: B
authors.lastname: Dasgupta
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012507:Sarcoidosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; C000591237:CT-P13; D007166:Immunosuppressive Agents; D000069285:Infliximab